Tag: Annamycin

April 29, 2018

5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent

Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 25, 2018

Moleculin Enters Agreement with BSP Pharmaceuticals for its Leukemia Drug Candidate

Moleculin Biotech (NASDAQ: MBRX) a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of which are...
April 4, 2018

Moleculin Announces Patients Treated in FDA Approved Phase I/II Annamycin Clinical Trial

Moleculin Biotech (NASDAQ: MBRX) a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of which are...
April 1, 2018

5 Top NASDAQ Biotech Stocks: Cardiome on Top

Cardiome, Avid, XBiotech, Fennec and Compugen were last week's five top-gaining NASDAQ biotech stocks. See what moved their share prices.
March 28, 2018

Moleculin Biotech Reports Financial Results for the Year Ended December 31, 2017

Moleculin Biotech (NASDAQ: MBRX) a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of which are...
March 27, 2018

Moleculin Enters Agreement with Seidman Cancer Center to Conduct Leukemia Clinical Trials

Moleculin Biotech (NASDAQ: MBRX) a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of which are...
March 18, 2018

5 Top NASDAQ Biotech Stocks: Second Sight Medical on Top

Second Sight, Juniper, Athersys, Aptose and ArQule were last week's five top-gaining NASDAQ biotech stocks. See what moved their share...